Zydus Lifesciences gets NoC for generic Liothyronine tablets 5 mcg, 25 mcg

07 Oct 2025 Evaluate

Zydus Lifesciences has received Notice of Compliance (NoC) from Health Canada for generic Liothyronine tablets 5 mcg and 25 mcg. Liothyronine tablets, a synthetic form of the thyroid hormone T3 (triiodothyronine), are primarily indicated for treating hypothyroidism.

ZDS- Liothyronine tablets will be manufactured at Zydus’ plant in Ahmedabad SEZ. Liothyronine tablets had annual sales of 10.9 mn Canadian Dollars in Canada (IQVIA MAT June 2025). 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

918.95 5.10 (0.56%)
19-Dec-2025 10:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1748.15
Dr. Reddys Lab 1287.10
Cipla 1509.15
Zydus Lifesciences 918.95
Lupin 2137.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×